Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7A6C

Nanodisc reconstituted human ABCB1 in complex with MRK16 Fab and elacridar

Summary for 7A6C
Entry DOI10.2210/pdb7a6c/pdb
Related7A65 7A69
EMDB information11670
DescriptorMultidrug resistance protein 1, If kappa light chain, MRK16 Fab-fragment heavy chain, ... (5 entities in total)
Functional Keywordsp-glycoprotein, mdr1, nanodisc, transport protein
Biological sourceHomo sapiens (Human)
More
Total number of polymer chains3
Total formula weight194177.60
Authors
Nosol, K.,Locher, K.P. (deposition date: 2020-08-25, release date: 2020-10-14, Last modification date: 2024-11-13)
Primary citationNosol, K.,Romane, K.,Irobalieva, R.N.,Alam, A.,Kowal, J.,Fujita, N.,Locher, K.P.
Cryo-EM structures reveal distinct mechanisms of inhibition of the human multidrug transporter ABCB1.
Proc.Natl.Acad.Sci.USA, 117:26245-26253, 2020
Cited by
PubMed Abstract: ABCB1 detoxifies cells by exporting diverse xenobiotic compounds, thereby limiting drug disposition and contributing to multidrug resistance in cancer cells. Multiple small-molecule inhibitors and inhibitory antibodies have been developed for therapeutic applications, but the structural basis of their activity is insufficiently understood. We determined cryo-EM structures of nanodisc-reconstituted, human ABCB1 in complex with the Fab fragment of the inhibitory, monoclonal antibody MRK16 and bound to a substrate (the antitumor drug vincristine) or to the potent inhibitors elacridar, tariquidar, or zosuquidar. We found that inhibitors bound in pairs, with one molecule lodged in the central drug-binding pocket and a second extending into a phenylalanine-rich cavity that we termed the "access tunnel." This finding explains how inhibitors can act as substrates at low concentration, but interfere with the early steps of the peristaltic extrusion mechanism at higher concentration. Our structural data will also help the development of more potent and selective ABCB1 inhibitors.
PubMed: 33020312
DOI: 10.1073/pnas.2010264117
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3.6 Å)
Structure validation

237735

數據於2025-06-18公開中

PDB statisticsPDBj update infoContact PDBjnumon